| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo,...
Barclays analyst Guy Hardwick initiates coverage on Symbotic (NASDAQ:SYM) with a Underweight rating and announces Price Targ...
UBS analyst Damian Karas downgrades Symbotic (NASDAQ:SYM) from Neutral to Sell and raises the price target from $27 to $35.